R22P (p.Arg22Pro) variant of SDHD (O14521)
R22P (p.Arg22Pro) in SDHD (O14521) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Pheochromocytoma; Paragangliomas with sensorineural hearing loss; Carney-Stratak. The available variant effect predictions contribute to a CATVariant prioritization score of 0.42 / 1. The record also includes published literature and structural context.
R22P (p.Arg22Pro) variant details
- p.Arg22Pro
- rs1555186772
- ClinGen CA382616926
- ClinVar RCV002604828
- ClinVar RCV006292220
- Uncertain significance
- Pheochromocytoma; Paragangliomas with sensorineural hearing loss; Carney-Stratak
- Missense
- Variant Prioritization Score for Impact Estimate 0.422
- AlphaMissense 0.08
- MetaLR 0.59
- MetaSVM -0.33
- PolyPhen-2 0.00
- SIFT 0.14
- EVE 0.14
- ClinVar: Uncertain significance (Pheochromocytoma; Paragangliomas with sensorineural hearing loss)
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Structural context available
- Cited in: Cancer Genetics Risk Assessment and Counseling (PDQ®): Health Professional Version. (PMID 26389258)
- Cited in: Genetics of Endocrine and Neuroendocrine Neoplasias (PDQ®): Health Professional Version. (PMID 26389271)